- Jun 17
- 7 min read
Updated: 4 days ago
Table of Content:
|
Introduction
Xinling (alias) was six years old, and she had been tired for weeks — the kind of tired that doesn't lift after sleep, that sits heavy behind the eyes and turns food tasteless. Her mother had taken her first to the county hospital near their home in a small town in Hubei Province, where doctors told them it was simple anemia, nothing to worry about. But Xinling only got worse. Eventually, they made the longer journey to the city of Wuhan, where a team of doctors ran more thorough tests and asked her mother to step into a private office.
Her mother was inside for half an hour. When she came out, her eyes were red at the rims. But she was smiling — the kind of smile that takes effort to hold.
“We’re going to stay and get some injections,” she said, squeezing Xinling’s hand. “You’ll feel better soon.”
What she didn’t say was the diagnosis written on the file in the doctor’s hands: acute lymphoblastic leukemia — ALL — a cancer of the blood and bone marrow, and the most common form of childhood leukemia.
The Family Behind the Diagnosis
To understand what this diagnosis meant, you have to understand who the family was. They lived modestly in rural Hubei. Both of Xinling’s parents had physical disabilities that qualified them for second-degree disability status under Chinese law — meaning their bodies already carried burdens most families never face. Her older sister, just twenty that summer, was at the age when young women think about fashion and futures. And then, in the span of one hospital visit, all of that ordinary life was put on hold.
Four days after the diagnosis, Xinling’s father disappeared. His phone went unanswered. He didn’t come to the hospital. The family later learned he had simply left — overwhelmed by the terror of spending everything they had and still losing his daughter, he chose not to face it. Days after that, Xinling’s grandmother arrived with relatives and went straight to the doctors. “Stop the treatment,” she pleaded. “This is a bottomless pit.” She reportedly tried to remove the IV line from Xinling’s arm. Her mother stood between her daughter and the door.
“My daughter still has hope,” she said, her voice breaking. “I am not giving up.”
The Infection, The Surgery, The Decision
The early treatments were punishing. Within the first cycle of chemotherapy — a treatment that uses powerful drugs to kill rapidly dividing cancer cells — Xinling’s immune system crashed. A fungal infection took hold. Then appendicitis struck, dangerous in any child; in Xinling’s case, her platelet counts were so low that emergency surgery carried enormous risk. Her mother signed the consent form with shaking hands.
Xinling survived. But the local hospital was honest with the family: they didn’t have the infrastructure for the next phase of treatment. Bone marrow transplantation, if it came to that, would need to happen somewhere else — Beijing or Shanghai. Her mother didn’t pause to deliberate. She packed their things and bought train tickets north.
On the train, she still hadn’t chosen a hospital. She held Xinling and cried quietly until her phone rang. A woman they’d befriended during the Wuhan treatment — a mother who had been through the same nightmare — called with a single, simple sentence: “Go to the specialized hematology hospital. My child was treated there. He’s doing well.” That one phone call set their course.
Arriving in Yanjiao
When they arrived at the specialized hematology center outside Beijing — a dedicated blood cancer hospital in the Yanjiao area — Xinling’s new attending physician came to meet her. Dr. Mei Lin (alias) was a quiet, composed woman in a white coat who knelt slightly to be at eye level with the small girl.
“Your name is Xinling?” she said, taking the child’s hand. “That’s a beautiful name. From now on, we’re going to be friends. We’ll get through this together, okay?”
The Treatment Journey
The treatment protocol was not simple. Xinling’s leukemia carried a specific chromosomal marker — TEL/AML1 positive — which, while not the highest-risk classification, had not responded well to her initial chemotherapy in Wuhan. The team designed an individualized plan around her particular biology, her compromised immune status, and the family’s precarious finances, which required them to time and reconsider every step. At this point in 2012, neither bone marrow transplantation nor CAR-T therapy — a revolutionary technique that reprograms a patient’s own immune cells to seek and destroy cancer — was available to Xinling as an option. The team had to rely on intensive chemotherapy alone, calibrated carefully.
The side effects were relentless. Nausea came with every infusion. Food was impossible. Xinling lost her hair in fistfuls until there was none left. She was a small, bald girl in a hospital bed, wearing a mask, playing board games with other children who wore masks and had no hair either. Nobody thought it was strange. They all understood each other’s pain without having to explain it.
The Meal She Never Forgot
There came a day when Xinling’s mother had to travel back to Wuhan to handle insurance reimbursement paperwork — a bureaucratic necessity that couldn’t be handled remotely. Xinling was still on an IV drip. Her mother was frantic, mentioning to Dr. Mei Lin in passing that she didn’t know what to do about lunch. Dr. Mei Lin said: “Go. We’ll take care of her.”
The next morning during rounds, Dr. Mei Lin stopped at Xinling’s bedside with a casual question: “So, what do you feel like eating for lunch today?” Xinling burst into tears.
Near noon, a nurse arrived carrying a thermal food container. She helped Xinling sit up, opened the lid, and stayed while the child ate every bite.
Twenty years on, Xinling still describes it as the best meal of her life. Not because of what was in the container, but because of what it meant — someone sees you, someone is here, you are not alone.
A Ward Full of People Who Understood
In the years that followed — chemotherapy has a long tail, with maintenance phases stretching years beyond the initial intense treatment — Xinling became part of a community she hadn’t expected. The long-term patients and their families in the ward became something like an extended family. No WeChat in those years, just QQ group chats, board games in the corridor, dumplings passed between beds at Lunar New Year.
Xinling’s mother, despite her own disability, became quietly indispensable to the group. She tracked down cheaper rental apartments near the hospital for other families. She wrote out handwritten notes explaining how to navigate the insurance reimbursement system and passed them to newly arrived parents. When a girl in a nearby bed wept through her chemotherapy and refused to continue, Xinling’s mother went every day to sit with her, made her plain rice porridge, and talked her through it. That girl recovered. She still sends gifts from her hometown.
Her mother always said:
“When you’re all going through hard times together, helping each other is the only way any of you get through.”
Growing Up: School, Shyness, and Finding Her Voice
Treatment ended. And then came the quieter challenge: re-entering a world that had moved on without her.
Xinling had missed almost all of primary school. She went directly into middle school, a year or two older than her classmates, thin and quiet and deeply uncertain. She sat in corners. She didn’t speak much. She was terrified of what people would think if they knew.
Eventually, with her mother’s encouragement, she took a breath and told her class teacher — asking for confidentiality. The teacher responded by making her class monitor, forcing her, gently, into connection with her peers.
It worked. Slowly, classmates offered notes and saved seats. Xinling discovered she could talk to people. Her personality opened. Through high school, she developed the habit — stubborn and useful — of preparing for every lesson in advance and reviewing it afterward, of never letting a question go unasked. She graduated. She sat her university entrance exams. She scored over 520 points.
At Twenty
This summer, Xinling turned twenty and prepared to begin university in Wuhan. She also made a photo album — a handmade one, with photographs from before her diagnosis, from the treatment years when she was a small bald girl in a hospital mask, and from now. She brought it to a patient reunion at the hospital and gave it to Dr. Mei Lin and the nurses. She wanted them to see: the little bald girl you looked after grew up.
Among the group of children who were treated alongside her, the outcomes are varied and human and real. One young man chose a nursing degree after recovery, wanting to wear a white coat and help people. Another young woman is studying dental medicine. A boy who used to play flying chess with Xinling in the ward just received his acceptance letter to a top high school in Wuhan. Everyone celebrated in the group chat.
A Closing Thought
Leukemia is not a story that ends cleanly. It stretches, it interrupts, it asks things of families that most people will never be asked. But Xinling’s story — and the stories of the children she grew up alongside in those hospital corridors — is a reminder that the disease does not get to write the whole chapter.
Some of those children are now in universities, clinics, and hospital wards of their own. They are studying, interning, falling in love, making plans. They are exactly what they were always going to be, just a few years later than expected.
What Patients Say About ChinaCureLink & Medebound HEALTH
ChinaCureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.
Rated 4.6 ⭐⭐⭐⭐⭐ at Trustpilot
Medebound HEALTH's online testimonials. Learn More
About ChinaCureLink
ChinaCureLink helps patients across the world — access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top 5 cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team that understands both the medical and cultural needs of Southeast Asian patients.
ChinaCureLink is proudly affiliated with Medebound HEALTH— an international medical concierge company headquartered in New York, specialized in securing premium second opinions from top US hospitals and specialists. With over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized as one of the leading patient access services across North America and the Asia Pacific, Medebound HEALTH brings the same standard of expert care coordination to every patient we serve.
This article is for informational purposes only and does not constitute medical advice. All treatment decisions should be made in consultation with a qualified oncologist who has reviewed your complete medical history and current diagnostic information.
Comments